From the Harvard Medical School, Boston, MA (Eruchalu)
Center for Surgery and Public Health, Department of Surgery (Eruchalu, Bergmark, Smink, Nguyen, Cooper, Ortega), Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
Division of General and Gastrointestinal Surgery, Department of Surgery (Smink, Tavakkoli), Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
Laboratory for Surgical and Metabolic Research (Tavakkoli), Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
Division of Vascular and Endovascular Surgery, Department of Surgery (Nguyen), Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
Division of General Internal Medicine, Department of Medicine (Bates), Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
Division of Trauma, Burn, and Surgical Critical Care, Department of Surgery (Cooper), Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
the Department of Health Policy and Management, Harvard T.H. Chan School of Public Health, Boston, MA (Bates).
Correspondence address: Gezzer Ortega, MD, MPH, Center for Surgery and Public Health, Brigham and Women’s Hospital, Harvard Medical School, One Brigham Circle, 1620 Tremont St, Suite 2-016, Boston, MA 02120. email: [email protected]
Disclosure Information: Nothing to disclose.
Disclosures outside the scope of this work: Dr Bates is a paid consultant to CDI Negev and AESOP Technology; receives grant funding from EarlySense and IBM Watson Health Technology; and holds stock in ValeraHealth, Clew, MDClone, LTD, and AESOP Technology. The other authors have nothing to disclose.
Presented virtually at the American College of Surgeons 107th Annual Clinical Congress, October 2021.
Supplemental digital content for this article is available at https://links.lww.com/XCS/A19.
Received August 11, 2021; Revised September 30, 2021; Accepted October 5, 2021.